688273 麦澜德
交易中 06-05 14:33:18
资讯
新帖
简况
每周股票复盘：麦澜德（688273）高管陈江宁减持4.07万股
证券之星 · 05-31
每周股票复盘：麦澜德（688273）高管陈江宁减持4.07万股
麦澜德：5月27日至5月28日高级管理人员陈江宁减持股份合计4.07万股
证券之星 · 05-29
麦澜德：5月27日至5月28日高级管理人员陈江宁减持股份合计4.07万股
5月29日麦澜德跌7.64%，中银健康生活混合A基金重仓该股
证券之星 · 05-29
5月29日麦澜德跌7.64%，中银健康生活混合A基金重仓该股
5月28日麦澜德涨7.57%，中银健康生活混合A基金重仓该股
证券之星 · 05-28
5月28日麦澜德涨7.57%，中银健康生活混合A基金重仓该股
麦澜德涨7.57%，华源证券一日前给出“买入”评级
证券之星 · 05-28
麦澜德涨7.57%，华源证券一日前给出“买入”评级
5月27日麦澜德跌6.66%，中银健康生活混合A基金重仓该股
证券之星 · 05-27
5月27日麦澜德跌6.66%，中银健康生活混合A基金重仓该股
麦澜德：温和放量反弹，业绩短期承压
E药资本界 · 05-26
麦澜德：温和放量反弹，业绩短期承压
麦澜德（688273）披露2025年年度权益分派实施公告，5月20日股价下跌1.88%
证券之星 · 05-20
麦澜德（688273）披露2025年年度权益分派实施公告，5月20日股价下跌1.88%
每周股票复盘：麦澜德（688273）召开2025年年度股东会
证券之星 · 05-10
每周股票复盘：麦澜德（688273）召开2025年年度股东会
麦澜德（688273）披露召开2025年度暨2026年第一季度业绩暨现金分红说明会公告，5月7日股价上涨4.68%
证券之星 · 05-07
麦澜德（688273）披露召开2025年度暨2026年第一季度业绩暨现金分红说明会公告，5月7日股价上涨4.68%
麦澜德（688273）披露持续督导跟踪总结报告书，5月6日股价下跌7.62%
证券之星 · 05-06
麦澜德（688273）披露持续督导跟踪总结报告书，5月6日股价下跌7.62%
每周股票复盘：麦澜德（688273）募投项目延期至2026年12月31日
证券之星 · 05-02
每周股票复盘：麦澜德（688273）募投项目延期至2026年12月31日
麦澜德（688273）披露高级管理人员减持股份计划公告，4月20日股价下跌2.52%
证券之星 · 04-20
麦澜德（688273）披露高级管理人员减持股份计划公告，4月20日股价下跌2.52%
麦澜德(688273)3月31日股东户数0.83万户，较上期增加21.67%
证券之星 · 04-16
麦澜德(688273)3月31日股东户数0.83万户，较上期增加21.67%
麦澜德最新公告：第一季度净利润同比下降42.49%
证券之星 · 04-15
麦澜德最新公告：第一季度净利润同比下降42.49%
麦澜德新提交“美限衡律”、“美限露羽”等4件商标注册申请
证券之星 · 04-10
麦澜德新提交“美限衡律”、“美限露羽”等4件商标注册申请
股市必读：麦澜德（688273）3月20日收盘跌10.23%，主力净流出4107.38万元
证券之星 · 03-23
股市必读：麦澜德（688273）3月20日收盘跌10.23%，主力净流出4107.38万元
中银国际：全球首款侵入式脑机产品获批 行业迈入商业化验证期
智通财经 · 03-16
中银国际：全球首款侵入式脑机产品获批 行业迈入商业化验证期
3月12日麦澜德涨5.67%，南华丰汇混合A基金重仓该股
证券之星 · 03-12
3月12日麦澜德涨5.67%，南华丰汇混合A基金重仓该股
3月3日麦澜德跌7.64%，南华丰汇混合A基金重仓该股
证券之星 · 03-03
3月3日麦澜德跌7.64%，南华丰汇混合A基金重仓该股
加载更多
公司概况
公司名称：
南京麦澜德医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2022-08-11
主营业务：
南京麦澜德医疗科技股份有限公司的主营业务是盆底及妇产康复领域相关医疗器械产品的研发、生产、销售和服务。公司的主要产品是多模态生物刺激反馈系统、雷达磁刺激仪、脑电近红外闭环经颅磁刺激仪、超声波治疗仪、中频治疗仪。
发行价格：
40.29
{"stockData":{"symbol":"688273","market":"SH","secType":"STK","nameCN":"麦澜德","latestPrice":41.9,"timestamp":1780641198000,"preClose":42.74,"halted":0,"volume":3614270,"delay":0,"changeRate":-0.0197,"floatShares":100000000,"shares":100000000,"eps":0.857,"marketStatus":"交易中","change":-0.84,"latestTime":"06-05 14:33:18","open":42.69,"high":44.87,"low":41.56,"amount":157000000,"amplitude":0.0774,"askPrice":41.93,"askSize":2,"bidPrice":41.91,"bidSize":3,"shortable":0,"etf":0,"ttmEps":0.857,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1780642800000},"marketStatusCode":2,"adr":0,"adjPreClose":42.74,"symbolType":"stock_kcb","openAndCloseTimeList":[[1780623000000,1780630200000],[1780635600000,1780642800000]],"highLimit":47.01,"lowLimit":38.47,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":100000000,"isCdr":false,"pbRate":3.12,"roa":"--","peRate":48.891482,"roe":"1.69%","epsLYR":1.0492,"committee":0,"marketValue":4190000000,"turnoverRate":0.0361,"status":1,"floatMarketCap":4190000000},"requestUrl":"/m/hq/s/688273/","defaultTab":"news","newsList":[{"id":"2639604314","title":"每周股票复盘：麦澜德（688273）高管陈江宁减持4.07万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639604314","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639604314?lang=zh_cn&edition=full","pubTime":"2026-05-31 02:53","pubTimestamp":1780167187,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，麦澜德报收于41.22元，较上周的43.2元下跌4.58%。本周，麦澜德5月27日盘中最高价报45.73元。麦澜德当前最新总市值41.22亿元，在医疗器械板块市值排名83/129，在两市A股市值排名3793/5207。股本股东变化高管增减持2026年5月27日至5月28日，公司高级管理人员陈江宁减持公司股份4.07万股，占公司总股本0.0407%。期间公司股价上涨0.4%，5月28日收盘价为44.63元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639251622","title":"麦澜德：5月27日至5月28日高级管理人员陈江宁减持股份合计4.07万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639251622","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639251622?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:01","pubTimestamp":1780056105,"startTime":"0","endTime":"0","summary":"证券之星消息，根据5月29日市场公开信息、上市公司公告及交易所披露数据整理，麦澜德最新董监高及相关人员股份变动情况：2026年5月27日至2026年5月28日公司高级管理人员陈江宁共减持公司股份4.07万股，占公司总股本为0.0407%。变动期间公司股价上涨0.4%，5月28日当日收盘报44.63元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900041222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639543628","title":"5月29日麦澜德跌7.64%，中银健康生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639543628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639543628?lang=zh_cn&edition=full","pubTime":"2026-05-29 16:37","pubTimestamp":1780043849,"startTime":"0","endTime":"0","summary":"证券之星消息，5月29日麦澜德跌7.64%，收盘报41.22元，换手率2.1%，成交量2.1万手，成交额9025.87万元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为中银基金的中银健康生活混合A。中银健康生活混合A目前规模为1.46亿元，最新净值2.1256，较上一交易日上涨1.15%，近一年上涨21.69%。中银健康生活混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900030206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638202665","title":"5月28日麦澜德涨7.57%，中银健康生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638202665","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638202665?lang=zh_cn&edition=full","pubTime":"2026-05-28 16:33","pubTimestamp":1779957213,"startTime":"0","endTime":"0","summary":"证券之星消息，5月28日麦澜德涨7.57%，收盘报44.63元，换手率2.7%，成交量2.7万手，成交额1.16亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为中银基金的中银健康生活混合A。中银健康生活混合A目前规模为1.46亿元，最新净值2.1015，较上一交易日下跌1.77%，近一年上涨21.69%。中银健康生活混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800028979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638665272","title":"麦澜德涨7.57%，华源证券一日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2638665272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638665272?lang=zh_cn&edition=full","pubTime":"2026-05-28 16:33","pubTimestamp":1779957205,"startTime":"0","endTime":"0","summary":"今日麦澜德（688273）涨7.57%，收盘报44.63元。2026年5月27日，华源证券研究员刘闯,林海霖发布了对麦澜德的研报《严肃、消费医疗协同发展，积极布局脑机接口业务》，该研报对麦澜德给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为73.04%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为光大证券的黄素青。麦澜德（688273）个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800028977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638570016","title":"5月27日麦澜德跌6.66%，中银健康生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638570016","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638570016?lang=zh_cn&edition=full","pubTime":"2026-05-27 16:27","pubTimestamp":1779870421,"startTime":"0","endTime":"0","summary":"证券之星消息，5月27日麦澜德跌6.66%，收盘报41.49元，换手率2.68%，成交量2.68万手，成交额1.15亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为中银基金的中银健康生活混合A。中银健康生活混合A目前规模为1.46亿元，最新净值2.1394，较上一交易日下跌0.96%，近一年上涨21.69%。中银健康生活混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700031531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511193","title":"麦澜德：温和放量反弹，业绩短期承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511193","media":"E药资本界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638511193?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:51","pubTimestamp":1779792660,"startTime":"0","endTime":"0","summary":"$XD麦澜德(688273) 麦澜德(688273.SH)今日收涨4.34%，报44.45元，成交额1.21亿元，换手率2.80%，量比1.64，日内振幅10.82%。 从基本面来看，公司2025年营收同比增长1.66%，净利润同比微增1.03%；2026年一季度净利润同比下滑42.49%，业绩短期承压。公司主营盆底及产后康复设备、生殖康复等业务，在康复医疗细分领域具备一定市场竞争力。 以上信息基于公开数据整理，不构成投资建议。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-26/doc-inhzfshe2730767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636884369","title":"麦澜德（688273）披露2025年年度权益分派实施公告，5月20日股价下跌1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636884369","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636884369?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:00","pubTimestamp":1779271250,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，麦澜德报收于42.86元，较前一交易日下跌1.88%，最新总市值为42.86亿元。该股当日开盘43.2元，最高43.8元，最低41.8元，成交额达5584.64万元，换手率为1.31%。公司于近日披露《2025年年度权益分派实施公告》，宣布每股派发现金红利0.50元（含税），不送红股，不进行公积金转增股本。股权登记日为2026年5月25日，除权（息）日为2026年5月26日，现金红利发放日为2026年5月26日。公司回购专用账户股份不参与分红。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634121664","title":"每周股票复盘：麦澜德（688273）召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2634121664","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634121664?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:37","pubTimestamp":1778355429,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，麦澜德报收于45.18元，较上周的46.75元下跌3.36%。公司公告汇总南京麦澜德医疗科技股份有限公司于2026年5月7日召开2025年年度股东会，会议由董事会召集，董事长杨瑞嘉主持，采用现场与网络投票方式表决。南京麦澜德医疗科技股份有限公司将于2026年5月20日9:00-10:00通过上证路演中心网络互动方式召开2025年度暨2026年第一季度业绩暨现金分红说明会，介绍公司经营成果、财务状况，并回答投资者提问。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633812641","title":"麦澜德（688273）披露召开2025年度暨2026年第一季度业绩暨现金分红说明会公告，5月7日股价上涨4.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633812641","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633812641?lang=zh_cn&edition=full","pubTime":"2026-05-07 22:48","pubTimestamp":1778165297,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，麦澜德报收于45.21元，较前一交易日上涨4.68%，最新总市值为45.21亿元。近日，南京麦澜德医疗科技股份有限公司发布《关于召开2025年度暨2026年第一季度业绩暨现金分红说明会的公告》。公告显示，公司将于2026年5月20日9:00-10:00通过上证路演中心网络互动方式召开说明会，介绍公司经营成果、财务状况，并回答投资者提问。投资者可于2026年5月13日至5月19日16:00前通过上证路演中心网站或公司邮箱提交问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700041625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633618625","title":"麦澜德（688273）披露持续督导跟踪总结报告书，5月6日股价下跌7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633618625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633618625?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:12","pubTimestamp":1778062379,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，麦澜德报收于43.19元，较前一交易日下跌7.62%，最新总市值为43.19亿元。近日，南京证券股份有限公司发布《关于南京麦澜德医疗科技股份有限公司持续督导跟踪总结报告书》。公告显示，南京证券作为麦澜德首次公开发行股票并在科创板上市的保荐机构，持续督导期自2022年8月11日至2025年12月31日。截至2025年末，募集资金余额43,524.67万元，保荐机构将继续履行剩余募集资金使用的持续督导责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600029480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623211","title":"每周股票复盘：麦澜德（688273）募投项目延期至2026年12月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623211","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632623211?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:28","pubTimestamp":1777674492,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，麦澜德报收于46.75元，较上周的46.91元下跌0.34%。本周，麦澜德4月27日盘中最高价报47.5元。督导期内，公司调整部分募投项目内部投资结构和总额，补充确认暂时闲置募集资金现金管理超额情形，并将募投项目整体延期至2026年12月31日。截至2025年末，募集资金余额43,524.67万元，保荐机构将继续履行剩余募集资金使用的持续督导责任。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628746236","title":"麦澜德（688273）披露高级管理人员减持股份计划公告，4月20日股价下跌2.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628746236","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628746236?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:37","pubTimestamp":1776677868,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘，麦澜德报收于47.67元，较前一交易日下跌2.52%，最新总市值为47.67亿元。近日，南京麦澜德医疗科技股份有限公司发布《高级管理人员减持股份计划公告》。公告显示，公司副总经理、董事会秘书陈江宁女士持有公司股份1,039,261股，占公司总股本的1.0393%，股份来源于首次公开发行前取得。因个人资金需求，陈江宁计划自公告披露日起15个交易日后的3个月内，通过集中竞价或大宗交易方式减持不超过259,815股，占公司总股本不超过0.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000024671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627953042","title":"麦澜德(688273)3月31日股东户数0.83万户，较上期增加21.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627953042","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627953042?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:11","pubTimestamp":1776330688,"startTime":"0","endTime":"0","summary":"证券之星消息，近日麦澜德披露，截至2026年3月31日公司股东户数为8270.0户，较12月31日增加1473.0户，增幅为21.67%。在医疗器械行业个股中，麦澜德股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年12月31日至2026年3月31日，麦澜德区间跌幅为11.69%，在此期间股东户数增加1473.0户，增幅为21.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600030587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627281088","title":"麦澜德最新公告：第一季度净利润同比下降42.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627281088","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627281088?lang=zh_cn&edition=full","pubTime":"2026-04-15 20:10","pubTimestamp":1776255010,"startTime":"0","endTime":"0","summary":"麦澜德(688273.SH)公告称，2026年第一季度实现营业收入9920.05万元，同比下降16.13%；归属于上市公司股东的净利润为2292.53万元，同比下降42.49%。业绩变动主要系因生产车间搬迁致阶段性停产，对公司产能释放及订单交付形成短期扰动，收入规模有所收缩；生产基地项目达到预定可使用状态，相关固定资产折旧费用较上期有所增加，拉动营业成本上行。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500039155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626155048","title":"麦澜德新提交“美限衡律”、“美限露羽”等4件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2626155048","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626155048?lang=zh_cn&edition=full","pubTime":"2026-04-10 06:38","pubTimestamp":1775774287,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日南京麦澜德医疗科技股份有限公司新提交“美限衡律”、“美限露羽”等4件商标注册申请。商标申请详情如下：今年以来南京麦澜德医疗科技股份有限公司新申请注册商标4件，截止目前公司共持有注册商标418件，另有34件商标尚在注册申请中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000005871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621743968","title":"股市必读：麦澜德（688273）3月20日收盘跌10.23%，主力净流出4107.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621743968","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621743968?lang=zh_cn&edition=full","pubTime":"2026-03-23 01:06","pubTimestamp":1774199173,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，麦澜德报收于42.89元，下跌10.23%，换手率4.48%，成交量4.48万手，成交额2.02亿元。当日关注点来自交易信息汇总：麦澜德股价3月20日下跌10.23%，收报42.89元，当日成交447.57万元，主力资金净流出4107.38万元。资金流向3月20日主力资金净流出4107.38万元，占总成交额的20.34%；游资资金净流入1426.93万元，占总成交额的7.07%；散户资金净流入2680.45万元，占总成交额的13.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300000397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619458178","title":"中银国际：全球首款侵入式脑机产品获批 行业迈入商业化验证期","url":"https://stock-news.laohu8.com/highlight/detail?id=2619458178","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619458178?lang=zh_cn&edition=full","pubTime":"2026-03-16 16:05","pubTimestamp":1773648327,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中银国际发布研报称，近日，国家药监局批准博睿康植入式脑机接口手部运动功能代偿系统创新产品注册申请，实现脑机接口全球首发上市，标志中国脑机接口产业从“技术验证”迈向“商业化落地”。投资建议随着全球首款侵入式产品获批上市，国内脑机接口产业已进入商业化验证期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中银国际：全球首款侵入式脑机产品获批 行业迈入商业化验证期","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0236","BK0077","300753","301363","002173","BK0096","BK0114","688626","BK0251","688580","301293","688273","301087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618181466","title":"3月12日麦澜德涨5.67%，南华丰汇混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618181466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618181466?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:21","pubTimestamp":1773303708,"startTime":"0","endTime":"0","summary":"证券之星消息，3月12日麦澜德涨5.67%，收盘报48.8元，换手率4.5%，成交量4.5万手，成交额2.14亿元。重仓麦澜德的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家；过去90天内机构目标均价为56.65。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为南华基金的南华丰汇混合A。南华丰汇混合A目前规模为5.29亿元，最新净值2.1181，较上一交易日上涨0.18%，近一年上涨54.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200026014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616317811","title":"3月3日麦澜德跌7.64%，南华丰汇混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616317811","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616317811?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:36","pubTimestamp":1772526979,"startTime":"0","endTime":"0","summary":"证券之星消息，3月3日麦澜德跌7.64%，收盘报41.56元，换手率1.9%，成交量1.9万手，成交额8154.63万元。重仓麦澜德的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家；过去90天内机构目标均价为56.65。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为南华基金的南华丰汇混合A。南华丰汇混合A目前规模为5.29亿元，最新净值2.1161，较上一交易日下跌1.5%，近一年上涨59.46%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300029012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780641201200,"stockEarnings":[{"period":"1week","weight":-0.0423},{"period":"1month","weight":-0.0753},{"period":"3month","weight":-0.0057},{"period":"6month","weight":0.2285},{"period":"1year","weight":0.5097},{"period":"ytd","weight":0.0167}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0132},{"period":"3month","weight":-0.0161},{"period":"6month","weight":0.0397},{"period":"1year","weight":0.2019},{"period":"ytd","weight":0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京麦澜德医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"8270人(较上一季度增加21.67%)","perCapita":"12091股","listingDate":"2022-08-11","address":"江苏省南京市江宁区华林路1号","registeredCapital":"10000万元","survey":" 南京麦澜德医疗科技股份有限公司的主营业务是盆底及妇产康复领域相关医疗器械产品的研发、生产、销售和服务。公司的主要产品是多模态生物刺激反馈系统、雷达磁刺激仪、脑电近红外闭环经颅磁刺激仪、超声波治疗仪、中频治疗仪。","listedPrice":40.29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"麦澜德(688273)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供麦澜德(688273)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"麦澜德,688273,麦澜德股票,麦澜德股票老虎,麦澜德股票老虎国际,麦澜德行情,麦澜德股票行情,麦澜德股价,麦澜德股市,麦澜德股票价格,麦澜德股票交易,麦澜德股票购买,麦澜德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"麦澜德(688273)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供麦澜德(688273)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}